Results 251 to 260 of about 113,542 (365)
QTc Interval and Its Associated Factors in Patient With Type 2 Diabetic Mellites. [PDF]
Asmare DS +4 more
europepmc +1 more source
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch +9 more
wiley +1 more source
Long QT interval syndrome type 2 caused by a new missense mutation of KCNH2 gene: A case report. [PDF]
Ma Y, Wang L, Wu S, Peng C.
europepmc +1 more source
Abstract The oral, small molecule inhibitor of activin receptor‐like kinase‐2, zilurgisertib (INCB000928), is under evaluation in fibrodysplasia ossificans progressiva. Cardiac safety was assessed using electrocardiogram (ECG) parameters and a plasma concentration‐heart rate‐corrected QT (C‐QTc) interval analysis of pooled data from single ascending ...
Yan‐ou Yang +5 more
wiley +1 more source
Učinak pentadekapeptida BPC 157 na produljeni QT interval u štakora uzrokovan ponavljanim dozama antipsihotika i antiemetika [The influence of pentadecapeptide BPC 157 on prolonged QT interval in rats caused with repetitive doses of antipsyhotics and antiemetics] [PDF]
Dean Strinić
openalex
Large Language Models for Clinical Trial Protocol Assessments
The purpose was to evaluate the utility of large language models (LLMs) for reviewing the statistical analysis plan (SAP) and pharmacokinetics–pharmacodynamics (PK–PD) components of clinical trial protocols. Clinical trial protocols and SAPs were obtained from clinicaltrials.gov for a testbed of 15 small‐molecule drugs, biologics, and global antibiotic
Euibeom Shin +2 more
wiley +1 more source
Potential adverse drug events can be signaled in Clinical Decision Support Systems (CDSSs). This study validated a Swedish CDSS (Janusmed Risk Profile) by investigating associations between calculated risk classifications of drugs with QT‐prolonging potential and registered related clinical outcomes.
Ola Nordqvist +6 more
wiley +1 more source
Abstract Background Territory‐wide epidemiological studies of acute Chinese medicine poisoning involving aconite after 2010 are lacking. Objectives To characterise the latest trends, presumed causes, clinical presentations, healthcare utilisation and patient outcomes of such poisoning cases in Hong Kong.
Rex Pui Kin Lam +9 more
wiley +1 more source

